Zealand Pharma — December 2021
-
Hvordan kan du udlede det, da Zealand selv omtaler licensaftaler, mens du henviser til et enkelt studie? Der må være en forskel mellem flertalsomtalen jf. indlæg fra Exit og din forklaring på BI studiet.
-
Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial
and
Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial
The iLet
Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use.https://www.proinvestor.com/index.php?p=debat_1&postid=99631 -
tak
-
Capital Group øger sin beholdning til 5.61 %
-
SMALLCAP World Fund
SMALLCAP World Fund - A | American FundsSMALLCAP World Fund - A | American Funds
SMALLCAP World Fund (Class A | Fund 35 | SMCWX) seeks to provide long-term growth of capital.
(www.capitalgroup.com)
-
Zealand Pharma: The Capital Group
Companies ejer 5,61 pct. af aktierne https://www.proinvestor.com/investornyt/755040/zealand-pharma-the-capital-group-companies-ejer-561-pct-af-aktierne -
Der må vel også snart komme fase II resultater fra Boehringer Ingelheim/Zealand for GLP-1/Glucagon dual analogen, eftersom det kliniske studie har været markeret som "completed" på clinicaltrials.gov siden november. Desuden er fedmestudiet med samme molekyle nu "Active, not recruiting", så de må have rekrutteret og randomiseret alle patienter til det studie
-
tak - ja må være lige oppeover
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind